Literature DB >> 2426089

Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells.

S Jin, F J Hornicek, D Neylan, M Zakarija, J M McKenzie.   

Abstract

Thyroid function, including growth, is TSH dependent, and most metabolic functions of TSH are thought to be mediated by cAMP. Recently, it has been suggested by several groups that growth may be an exception and that it may not be related to cAMP action. In addition, evidence has accrued indicating that the thyroid-stimulating antibody (TSAb) of Graves' disease, the metabolic actions of which are also cAMP mediated, may not be the goitrogenic agent in that syndrome. To evaluate these concepts, we used functioning rat thyroid cells (FRTL5) in monolayer culture and, as indices of growth, the incorporation of [3H]thymidine ([3H]Tdr) into DNA, the concentration of DNA measured directly, and the percentage of cells in S phase, as assessed by flow cytometry, all studied over 72 h of incubation. TSH, forskolin, and cholera toxin enhanced growth by each criterion and increased the concentration of cAMP in parallel; the effect on cAMP occurred rapidly and was maximal well in advance of influences on growth. In all instances, measures of growth promotion were minimal at 24 h and maximal at 48 h, except for [3H]Tdr incorporation, which was greater at 72 h than at 48 h. 3-Isobutyl-1-methylxanthine (IBMX) and (Bu)2 cAMP were also tested. Both enhanced all indices of growth and were as effective as TSH. Maximal responses to TSH were obtained at 100-200 microU/ml, maximal responses to both IBMX and (Bu)2cAMP occurred at 5 X 10(-4) M, and all three stimulators increased the DNA concentration and [3H]Tdr uptake and induced S phase in at least 20% of all cells in culture. The peak effect on DNA and S phase was consistently at 48 h. Epidermal growth factor (EGF) was shown to increase [3H]Tdr incorporation in a nondose-dependent fashion (10(-10) to 5 X 10(-9) M gave approximately 250% of control) over 1, 2, 3, 5, and 7 days, with no increase in DNA and a slight decrement in the concentration of cAMP. A laboratory standard TSAb-immunoglobulin G was shown to parallel TSH in both increasing cAMP (over 2 h of incubation) and growth stimulation (over 72 h). The data are entirely consistent with the view that TSH-stimulated thyroid growth is mediated by cAMP and that the established action of TSAb on adenylate cyclase is sufficient to explain goiter as well as hyperthyroidism in Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426089     DOI: 10.1210/endo-119-2-802

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Demonstration of the production and physiological role of insulin-like growth factor II in rat thyroid follicular cells in culture.

Authors:  R M Maciel; A C Moses; G Villone; D Tramontano; S H Ingbar
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

2.  Thyrotropin regulates adenosine A(1) receptor expression in rat thyroid FRTL-5 cells.

Authors:  M Vainio; B B Fredholm; K Törnquist
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH.

Authors:  L Croce; F Coperchini; M Tonacchera; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-05-17       Impact factor: 4.256

4.  Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.

Authors:  M Zakarija; S Jin; J M McKenzie
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.

Authors:  E Laurent; J Van Sande; M Ludgate; B Corvilain; P Rocmans; J E Dumont; J Mockel
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells.

Authors:  B M Veneziani; G Villone; R Romano; A Di Carlo; C Garbi; D Tramontano
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Thyroid-stimulating hormone and insulin-like growth factor-1 synergize to elevate 1,2-diacylglycerol in rat thyroid cells. Stimulation of DNA synthesis via interaction between lipid and adenylyl cyclase signal transduction systems.

Authors:  L Brenner-Gati; K A Berg; M C Gershengorn
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Effect of thyrotropin and cAMP on FRTL5 cell growth in a serum free medium.

Authors:  G Damante; D Russo; D Foti; G Grasso; S Filetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

9.  Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor.

Authors:  Koji Nakabayashi; Hirotaka Matsumi; Alka Bhalla; Jeehyeon Bae; Sietse Mosselman; Sheau Yu Hsu; Aaron J W Hsueh
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Intrinsic abnormality of thyroid cells from a patient with a Brobdingnagian goiter.

Authors:  Y C Tseng; K D Burman; J R Baker; J D'Avis; L Wartofsky
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.